{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:55:10Z","timestamp":1768550110403,"version":"3.49.0"},"posted":{"date-parts":[[2020,10,14]]},"group-title":"Public and Global Health","reference-count":21,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2020,10,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Prior studies examining symptoms of COVID-19 are primarily descriptive and measured among hospitalized individuals. Understanding symptoms of SARS-CoV-2 infection in pre-clinical, community-based populations may improve clinical screening, particularly during flu season. We sought to identify key symptoms and symptom combinations in a community-based population using robust methods.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We pooled community-based cohorts of individuals aged 12 and older screened for SARS-CoV-2 infection in April and June 2020 for a statewide seroprevalence study. Main outcome was SARS-CoV-2 positivity. We calculated sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for individual symptoms as well as symptom combinations. We further employed multivariable logistic regression and exploratory factor analysis (EFA) to examine symptoms and combinations associated with SARS-CoV-2 infection.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 8214 individuals screened, 368 individuals (4.5%) were RT-PCR positive for SARS-CoV-2. Although two-thirds of symptoms were highly specific (&gt;90.0%), most symptoms individually possessed a PPV &lt;50.0%. The individual symptoms most greatly associated with SARS-CoV-2 positivity were fever (OR=5.34, p&lt;0.001), anosmia (OR=4.08, p&lt;0.001), ageusia (OR=2.38, p=0.006), and cough (OR=2.86, p&lt;0.001). Results from EFA identified two primary symptom clusters most associated with SARS-CoV-2 infection: (1) ageusia, anosmia, and fever; and (2) shortness of breath, cough, and chest pain. Moreover, being non-white (13.6% vs. 2.3%, p&lt;0.001), Hispanic (27.9% vs. 2.5%, p&lt;0.001), or living in an Urban area (5.4% vs. 3.8%, p&lt;0.001) was associated with infection.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Symptoms can help distinguish SARS-CoV-2 infection from other respiratory viruses, especially in community or urgent care settings where rapid testing may be limited. Symptoms should further be structured in clinical documentation to support identification of new cases and mitigation of disease spread by public health. These symptoms, derived from asymptomatic as well as mildly infected individuals, can also inform vaccine and therapeutic clinical trials.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Research in Context<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Evidence before this study<\/jats:title>\n                    <jats:p>Using multiple journal articles queried from MEDLINE as well as a Cochrane systematic review, we examined all studies that described symptoms known to be associated with COVID-19. We further examined the guidelines from WHO and CDC on the symptoms those public health authorities consider to be associated with COVID-19. Most of the evidence comes from China, Italy, and the United States. Collectively prior research and guidance suggests there are a dozen symptoms reported by individuals who tested positive for COVID-19 in multiple countries. Symptoms include fever, cough, fatigue, anosmia, ageusia, shortness of breath, chills, myalgias, headache, sore throat, chest pain, and gastrointestinal issues. The evidence is generally of low quality as it is descriptive in nature, and it is biased towards hospitalized patients. Most studies report the proportion of patients hospitalized or testing positive for infection who report one or more symptoms within 3-14 days prior to hospitalization or infection. There has been little validation of symptoms among hospitalized or non-hospitalized patients. Furthermore, according to a Cochrane review, no studies to date assess combinations of different signs and symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Added value of this study<\/jats:title>\n                    <jats:p>This study employs multiple, rigorous methods to examine the ability of specific symptoms as well as symptom combinations\/groups to predict laboratory-confirmed (RT-PCR) infection of SARS-CoV-2. Furthermore, the study is unique in its large sample drawn exclusively from community-based populations rather than hospitalized patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implication of all the available evidence<\/jats:title>\n                    <jats:p>Combining the evidence from this study with prior research suggests that anosmia and ageusia are key symptoms that differentiate COVID-19 from influenza-like symptoms. Clinical screening protocols for COVID-19 should look for these symptoms, which are not commonly asked of patients who present to urgent care or hospital with flu-like symptoms.<\/jats:p>\n                  <\/jats:sec>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Key points<\/jats:title>\n                  <jats:p>Important symptoms specific to COVID-19 are fever, anosmia, ageusia, and cough. Two-thirds of symptoms were highly specific (&gt;90.0%), yet most symptoms individually possessed a PPV &lt;50.0%. This study confirms using robust methods the key symptoms associated with COVID-19 infection, and it also identifies combinations of symptoms strongly associated with positive infection<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2020.10.11.20210922","type":"posted-content","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T11:50:40Z","timestamp":1602676240000},"source":"Crossref","is-referenced-by-count":20,"title":["Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1121-0607","authenticated-orcid":false,"given":"Brian E.","family":"Dixon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3277-4452","authenticated-orcid":false,"given":"Kara","family":"Wools-Kaloustian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0292-6734","authenticated-orcid":false,"given":"William F.","family":"Fadel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1860-2774","authenticated-orcid":false,"given":"Thomas J.","family":"Duszynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9014-3651","authenticated-orcid":false,"given":"Constantin","family":"Yiannoutsos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7684-4363","authenticated-orcid":false,"given":"Paul K.","family":"Halverson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3411-2700","authenticated-orcid":false,"given":"Nir","family":"Menachemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2020102406200511000_2020.10.11.20210922v2.1","unstructured":"Centers for Disease Control and Prevention US. Symptoms of Coronavirus. 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/symptoms-testing\/symptoms.html (accessed May 5 2020)."},{"key":"2020102406200511000_2020.10.11.20210922v2.2","first-page":"91","article-title":"Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis","volume":"94","year":"2020","journal-title":"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases"},{"key":"2020102406200511000_2020.10.11.20210922v2.3","doi-asserted-by":"crossref","unstructured":"Pascarella G , Strumia A , Piliego C , et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med 2020.","DOI":"10.1111\/joim.13091"},{"issue":"7","key":"2020102406200511000_2020.10.11.20210922v2.4","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/s41591-020-0916-2","article-title":"Real-time tracking of self-reported symptoms to predict potential COVID-19","volume":"26","year":"2020","journal-title":"Nature Medicine"},{"issue":"7","key":"2020102406200511000_2020.10.11.20210922v2.5","first-page":"CD013665","article-title":"Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease","volume":"7","year":"2020","journal-title":"The Cochrane database of systematic reviews"},{"key":"2020102406200511000_2020.10.11.20210922v2.6","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6929e1"},{"key":"2020102406200511000_2020.10.11.20210922v2.7","doi-asserted-by":"crossref","unstructured":"Chow EJ , Schwartz NG , Tobolowsky FA , et al. Symptom Screening at Illness Onset of Health Care Personnel With SARS-CoV-2 Infection in King County, Washington. JAMA 2020.","DOI":"10.1001\/jama.2020.6637"},{"key":"2020102406200511000_2020.10.11.20210922v2.8","doi-asserted-by":"crossref","unstructured":"Wang Z , Yang B , Li Q , Wen L , Zhang R. Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China. Clinical Infectious Diseases 2020.","DOI":"10.1093\/cid\/ciaa272"},{"key":"2020102406200511000_2020.10.11.20210922v2.9","doi-asserted-by":"publisher","DOI":"10.1002\/nur.20323"},{"key":"2020102406200511000_2020.10.11.20210922v2.10","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-77"},{"issue":"6","key":"2020102406200511000_2020.10.11.20210922v2.11","doi-asserted-by":"crossref","first-page":"e19855","DOI":"10.2196\/19855","article-title":"Epidemiological Observations on the Association Between Anosmia and COVID-19 Infection: Analysis of Data From a Self-Assessment Web Application","volume":"22","year":"2020","journal-title":"J Med Internet Res"},{"issue":"7","key":"2020102406200511000_2020.10.11.20210922v2.12","first-page":"948","article-title":"Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19","volume":"26","year":"2020","journal-title":"Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"6","key":"2020102406200511000_2020.10.11.20210922v2.13","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jinf.2020.03.041","article-title":"Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis","volume":"80","year":"2020","journal-title":"J Infect"},{"key":"2020102406200511000_2020.10.11.20210922v2.14","doi-asserted-by":"crossref","unstructured":"Tong JY , Wong A , Zhu D , Fastenberg JH , Tham T. The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg 2020: 194599820926473.","DOI":"10.1177\/0194599820934760"},{"key":"2020102406200511000_2020.10.11.20210922v2.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.12603"},{"key":"2020102406200511000_2020.10.11.20210922v2.16","doi-asserted-by":"crossref","unstructured":"Coletta MA , Ising A. Syndromic Surveillance: A Practical Application of Informatics. In: Magnuson JA , Dixon BE , eds. Public Health Informatics and Information Systems. Cham: Springer International Publishing; 2020: 269\u201385.","DOI":"10.1007\/978-3-030-41215-9_16"},{"issue":"7","key":"2020102406200511000_2020.10.11.20210922v2.17","doi-asserted-by":"crossref","first-page":"e19902","DOI":"10.2196\/19902","article-title":"Health Observation App for COVID-19 Symptom Tracking Integrated With Personal Health Records: Proof of Concept and Practical Use Study","volume":"8","year":"2020","journal-title":"JMIR mHealth and uHealth"},{"key":"2020102406200511000_2020.10.11.20210922v2.18","doi-asserted-by":"crossref","unstructured":"Ming LC , Untong N , Aliudin NA , et al. Mobile Health Apps on COVID-19 Launched in the Early Days of the Pandemic: Content Analysis and Review. JMIR mHealth and uHealth 2020.","DOI":"10.2196\/preprints.19796"},{"key":"2020102406200511000_2020.10.11.20210922v2.19","unstructured":"Centers for Disease Control and Prevention US. COVID-19 in Racial and Ethnic Minority Groups. Jun 25 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/racial-ethnic-minorities.html (accessed Jul 25 2020)."},{"key":"2020102406200511000_2020.10.11.20210922v2.20","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6918e1"},{"key":"2020102406200511000_2020.10.11.20210922v2.21","unstructured":"National Center for Immunization and Respiratory Diseases, Division of Viral Diseases. Health Equity Considerations and Racial and Ethnic Minority Groups. 24 Jul 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/community\/health-equity\/race-ethnicity.html#fn1 (accessed Aug 29 2020)."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2020.10.11.20210922","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:56:25Z","timestamp":1768485385000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2020.10.11.20210922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,14]]},"references-count":21,"URL":"https:\/\/doi.org\/10.1101\/2020.10.11.20210922","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1371\/journal.pone.0241875","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2020,10,14]]},"subtype":"preprint"}}